The regulator said that one plausible explanation for the combination of blood clots and low blood platelets was an “immune response, leading to a condition similar to one seen sometimes in patients treated with heparin (heparin induced thrombocytopenia, HIT)”.
Support Our News Campaign
Shop our StoreClick Here To Shop
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe